NCT06510361
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06510361
Title A Phase 2 Study of Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a Complete Response With Upfront Chemoimmunotherapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Beth Israel Deaconess Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford RECRUITING Stanford California 94305 United States Details
Beth Israel Deaconess Medical Center RECRUITING Boston Massachusetts 02215 United States Details
Icahn School of Medicine at Mount Sinai RECRUITING New York New York 10029 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field